P96559 AF NFT

Vancomycin aglycone glucosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihdzrzoasf627w62hs3vmfxp4dhqmjq5grv4fcbsprlwbvbyhuoua/metadata.json
IPFS of structure file: 
bafybeidnvpfa3n4ximywffnxkfirn4wdbkcltgsxqzk2mu3wq66k62truq/AF-P96559-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xA1f8bc17CB3611090dDAE0D139DbBDcb586eDf26
First NFT owner address (bech32): 
genesis158utc97txcgsjrw6urgnnkaaedvxahexr50ct0
Current NFT ID #160962 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
160962
Accession (UniProt):
P96559
Name::
Vancomycin aglycone glucosyltransferase
Experimental Method:
Predicted structure
Sequence source:
AMYCOLATOPSIS ORIENTALIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P96559 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P96559|GTFB_AMYOR Vancomycin aglycone glucosyltransferase OS=Amycolatopsis orientalis OX=31958 GN=gtfB PE=1 SV=1 MRVLLATCGSRGDTEPLVALAVRVRDLGADVRMCAPPDCAERLAEVGVPHVPVGPSARAPIQRAKPLTAEDVRRFTTEAIATQFDEIPAAAEGCAAVVTTGLLAAAIGVRSVAEKLGIPYFYAFHCPSYVPSPYYPPPPLGEPSTQDTIDIPAQWERNNQSAYQRYGGLLNSHRDAIGLPPVEDIFTFGYTDHPWVAADPVLAPLQPTDLDAVQTGAWILPDERPLSPELAAFLDAGPPPVYLGFGSLGAPADAVRVAIDAIRAHGRRVILSRGWADLVLPDDGADCFAIGEVNHQVLFGRVAAVIHHGGAGTTHVAARAGAPQILLPQMADQPYYAGRVAELGVGVAHDGPIPTFDSLSAALATALTPETHARATAVAGTIRTDGAAVAARLLLDAVSREKPTVSA